Novaquest Capital Management
Overview
NovaQuest Capital Management provides a range of customized, structured finance investments to meet the needs of BioPhama companies.
Investment Focus
- Late-stage clinical and commercialized biopharmaceutical products
- Tech-enabled life sciences and pharmaceutical services companies
- Companies aiming to reduce total cost of care, fulfill unmet medical needs, and improve patient quality of life
Portfolio Companies
Reach Novaquest Capital Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Novaquest Capital Management
What sectors does Novaquest Capital Management invest in?
Novaquest Capital Management invests in Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Healthcare Equipment, and is based in Raleigh, United States. Novaquest Capital Management is listed as a vc in the ConnectSafely investor database.
What stage does Novaquest Capital Management invest at?
Novaquest Capital Management backs companies at Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 30M - 100M.
Which regions does Novaquest Capital Management invest in?
Novaquest Capital Management invests across United States and Global.
Who are the partners at Novaquest Capital Management?
Team members listed for Novaquest Capital Management include Bryan Mills (Partner & Chief Administrative Officer) and Robert Hester (Partner and Chief Financial Officer).
What companies has Novaquest Capital Management invested in?
Novaquest Capital Management's portfolio includes Cerevel Therapeutics, FibroGen, TARGAN, Catalyst Clinical Research, Vector Clinical Trials, MI:RNA, Hansen Biopharma and Gallant Therapeutics.
How do I contact Novaquest Capital Management?
Novaquest Capital Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
